IGNCX | PGNAX | IGNCX / PGNAX | |
Total Expense Ratio | 2.11 | 1.26 | 167% |
Annual Report Gross Expense Ratio | 2.45 | 1.26 | 194% |
Fund Existence | 29 years | 36 years | - |
Gain YTD | 10.415 | 10.539 | 99% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 173M | 682M | 25% |
Annual Yield % from dividends | 5.95 | 0.87 | 680% |
Returns for 1 year | 1.64 | -1.82 | -90% |
Returns for 3 years | 23.76 | 29.48 | 81% |
Returns for 5 years | 70.97 | 124.51 | 57% |
Returns for 10 years | 14.94 | 78.95 | 19% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FRBRX | 130.12 | 0.97 | +0.75% |
Franklin Biotechnology Discovery R6 | |||
NEAMX | 33.86 | 0.19 | +0.56% |
Neiman Large Cap Value A | |||
DWGAX | 12.53 | 0.03 | +0.24% |
American Funds Dvlpg Wld Gr&Inc A | |||
HILSX | 22.18 | 0.05 | +0.23% |
Hartford International Value R4 | |||
CRVRX | 8.08 | -0.01 | -0.12% |
NYLI CBRE Real Estate Fund Investor Cl |